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http:WHAT THIS PAPER ADDS
For the ﬁrst time, the impact of angiosome-targeted revascularization has been studied in terms of wound
healing and limb salvage. Unlike previous studies, the results of percutaneous transluminal angioplasty and
bypass surgery were compared according to the angiosome concept. Differences in outcomes after bypass
surgery and PTA were adjusted by estimating a propensity score, which was employed for one to one matching
as well as adjusted analysis.Objective: The aim of this study was to evaluate the impact of angiosome targeted revascularization according to
the revascularization method.
Design: Retrospective observational study.
Materials and methods: This study cohort comprised 744 consecutive patients who underwent infrapopliteal
endovascular or surgical revascularization between January 2010 and July 2013. Differences in outcomes after
bypass surgery and PTA were adjusted by estimating a propensity score, which was employed for one to one
matching as well as adjusted analysis.
Results: Cox proportional hazards analysis showed that angiosome-targeted revascularization (HR 1.29, 95% CI
1.02e1.65), bypass surgery (HR 1.79, 95% CI 1.41e2.27), C-reactive protein 10 mg/dL (HR 1.42, 95% CI 1.11e
1.81), and the number of affected angiosomes (HR 0.85, 95% CI 0.74e0.98) were independent predictors of
improved wound healing.When adjusted for the number of affected angiosomes and C-reactive protein 10 mg/
dL, angiosome-targeted bypass surgery was associated with a signiﬁcantly higher rate of wound healing than
non-angiosome-targeted angioplasty (HR 2.27, 95% CI 1.61e3.20). This was conﬁrmed in propensity score
adjusted analysis (HR 1.72, 95% CI 1.35e2.16). Among patients who underwent angiosome-targeted
revascularization, the propensity score adjusted analysis showed that bypass surgery was associated with a
signiﬁcantly better rate of wound healing (HR 154, 95% CI 1.09e2.16) but similar limb salvage rates when
compared with angioplasty (HR 0.79, 95% CI 0.44e1.43).
Conclusion: Rates of wound healing and limb salvage in patients with critical limb ischemia (CLI) were
signiﬁcantly better after angiosome-targeted revascularization, bypass surgery achieving signiﬁcantly better
wound healing than angioplasty.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The angiosome concept, which has been successfully used
in plastic surgery for years, has recently been the topic of
lively discussion in the ﬁeld of vascular and endovascular
surgery. In 2006, Attinger et al. described six angiosomal
regions in the foot and ankle, each supplied by one of the
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//dx.doi.org/10.1016/j.ejvs.2014.12.023knowledge, several consecutive studies have been carried
out applying the angiosome concept to the treatment of
critical limb ischaemia (CLI) with tissue lesions.3e17 Most of
the studies have compared so called targeted versus non-
targeted revascularization in patients who have under-
gone endovascular revascularization. Targeted revasculari-
zation is deﬁned as a percutaneous transluminal angioplasty
which achieves recanalization from the abdominal aorta to
the angiosomal artery.6 Two recent meta-analyses of
angiosome-targeted versus non-targeted revascularization
showed better results in terms of wound healing and limb
salvage for angiosome-targeted revascularization pro-
cedures.18,19 The main beneﬁts of angiosome-targeted
revascularization have been observed in patients with
Angiosome-Targeted Infrapopliteal Revascularization 413diabetes and renal failure.10,20,21 The very few studies
applying the angiosome concept in open surgical treatment
of CLI suggested that better wound healing is dependent on
the quality of the pedal arch rather than angiosome-guided
revascularization.11,17 No comparative analysis of surgical
versus endovascular angiosome-targeted and non-
angiosome-targeted revascularization of patients with CLI
and tissue loss(/lesions) has been performed so far, thus
this issue was investigated in the present study.MATERIAL AND METHODS
The vascular surgical center in this study is the only provider
of treatment of CLI in a population of 1.3 million in-
habitants, with an annual number of about 1,000 revascu-
larization procedures for CLI. About one third of the
patients are treated on an emergency basis, and 60e70% of
the patients are ﬁrst referred to the outpatient clinic for
evaluation and treatment of their CLI. The center has an
active policy for the treatment of CLI, whereby a patient is
declined for revascularization only if she/he is not mobile,
has progressive dementia, extremely short life-expectancy,
or no possibilities for revascularization. All patients un-
dergo magnetic resonance imaging (MRI) angiography if not
contraindicated, with the method for revascularization
chosen on the basis of the results. Usual practice for
revascularization is endovascular ﬁrst, but in cases with
extensive atherosclerosis and long occlusions, bypass is
preferred as a ﬁrst line treatment. Difﬁcult cases are dis-
cussed in a daily meeting of vascular surgeons and inter-
ventional radiologists. A rough threshold for CLI is toe
pressure 30 mmHg in patients without diabetes and
50 mmHg in diabetic patients, but in cases in whom there
is an evident arterial stenosis and non-healing wound,
intervention can be done at higher threshold pressure
values. The operative techniques offered have been
described in detail in previously published articles.6,22,23
This is a retrospective study including 744 consecutive
patients with CLI and tissue loss (Fontaine IV), who under-
went infrapopliteal endovascular or surgical revasculariza-
tion between January 2010 and July 2013. The study plan
was accepted by the ethical committee of the Helsinki
University Central Hospital.
Data collection was performed using a prospectively
collected database and scrutinized retrospectively by
reviewing patient records as well as patients’ angiograms. In
patients who underwent endovascular treatment, the an-
giograms were reviewed before and after the revasculari-
zation to evaluate whether the procedure had been
angiosome-targeted or not. In patients undergoing surgi-
cal bypass, the pre-operative MRI angiograms and digital
subtraction angiograms, if available, were reviewed as well.
The patients’ baseline characteristics and operative data
are summarized in Table 1.
Glomerular ﬁltration rate (eGFR) was estimated by the
Modiﬁcation of Diet in Renal Disease (MDRD) formula.31
Angiosome-targeted revascularization was deﬁned as any
angioplasty or bypass surgery procedure of the sourceartery perfusing the affected area, therefore aiming to
create direct ﬂow from the abdominal aorta into the
angiosomal source artery.5,6
Wound healing and limb salvage were the main outcome
endpoints of the study. Survival and amputation free sur-
vival were secondary endpoints.Statistical analysis
Statistical analysis was performed using SPSS statistical
software (SPSS v. 22.0, SPSS Inc., Chicago, IL, USA).
Continuous variables are reported as mean and standard
deviation. Nominal variables are reported as absolute
number and percentage. Pearson’s chi-square test, Fisher’s
exact test, and the ManneWhitney test were used for
univariate analysis. Long-term outcome was assessed by
KaplaneMeier’s method with the log-rank test and the Cox
proportional hazards method.
Differences between study groups were adjusted by
estimating a propensity score. The propensity score was
calculated by non-parsimonious logistic regression. Hosmer-
Lemeshow’s test was used to assess the regression model
ﬁt. Receiver operating characteristic (ROC) curve analysis
was used to estimate the area under the curve of the model
predicting the probability of being included in the groups of
patients with and without angiosome-targeted infrapopli-
teal revascularization. The calculated propensity score was
employed for one to one matching, as well as to adjust for
other variables in estimating their impact on the post-
operative outcome. One to one propensity score matching
between study groups was performed according to a caliper
width equal to 0.2 times the standard deviation of the
calculated propensity score’s logit. Outcome in the pro-
pensity matched pairs was evaluated by KaplaneMeier’s
methods as well as the Cox regression method. A p < .050
was considered statistically signiﬁcant.RESULTS
Wound healing
Univariate analysis showed that C-reactive protein 10 mg/
dL (p ¼ .002), bypass surgery as opposed to angioplasty
(p < .0001), crural as opposed to pedal revascularization
(p ¼ .001), and a low number of affected angiosomes
(p < .0001) were associated with improved foot wound
healing. Angiosome-targeted revascularization was associ-
ated with a trend towards better wound healing (p ¼ .071,
Table 2). The Cox proportional hazards analysis revealed
that angiosome-targeted revascularization (p ¼ .036, HR
1.294, 95% CI 1.017e1.647), bypass surgery (p < .0001, HR
1.791, 95% CI 1.412e2.272), C-reactive protein 10 mg/dL
(p ¼ .005, HR 1.416, 95% CI 1.110e1.806), and the fewer
angiosomes affected (p ¼ .024, HR 0.854, 95% CI 0.744e
0.979) improved wound healing. Actuarial analysis demon-
strated the positive impact of angiosome-targeted bypass
surgery on wound healing compared with angiosome-
targeted angioplasty (Log-rank: p < .0001, Fig. 1). When
adjusted for the number of affected angiosomes and C-
Table 1. Baseline characteristics and operative data on patients who underwent angiosome-targeted or non-angiosome-targeted
infrainguinal revascularization for critical limb ischaemia.
Patients characteristics Overall series Propensity matched pairs
Non-angiosome
targeted
336 pts
Angiosome-
targeted
408 pts
p Non-angiosome-
targeted
252 pts
Angiosome-
targeted
252 pts
p
Age, years 75.5  11.2 73.6  11.2 0.039 74.6  11.2 74.8  10.7 0.964
Age 80 years 142 (42.3) 153 (37.5) 0.186 99 (39.3) 107 (42.5) 0.469
Female sex 124 (36.9) 152 (37.3) 0.922 97 (38.5) 95 (37.7) 0.854
Smoking 48 (14.3) 60 (14.7) 0.871 37 (14.7) 35 (13.9) 0.799
Diabetes 201 (59.8) 258 (63.2) 0.340 160 (63.5) 157 (62.3) 0.782
C-reactive protein 46  54 48  54 0.703 47  55 43  51 0.326
Dyslipidaemia 78 (23.2) 116 (28.4) 0.107 65 (25.8) 67 (26.6) 0.839
Glomerular ﬁltration rate
(mL/min/1.73 m2)
75  35 76  38 0.944 76.3  36.8 74.7  36.8 0.477
Chronic kidney disease class 0.109 0.952
3A 53 (15.8) 48 (11.8) 37 (14.7) 40 (15.9)
3B 33 (9.8) 47 (11.5) 26 (10.3) 31 (12.3)
4 10 (3.0) 9 (2.2) 6 (2.4) 8 (3.2)
5 16 (4.8) 34 (8.3) 0.053 15 (6.0) 14 (5.6) 0.848
Dialysis 11 (3.3) 30 (7.4) 0.015 10 (4.0) 11 (4.4) 0.824
Kidney transplantation 6 (1.8) 9 (2.2) 0.685 4 (1.6) 5 (2.0) 1.000
Hypertension 222 (66.1) 248 (60.8) 0.137 163 (64.7) 165 (65.5) 0.852
Atrial ﬁbrillation 106 (31.5) 111 (27.2) 0.195 72 (28.6) 75 (29.8) 0.769
Coronary artery disease 133 (39.6) 135 (33.1) 0.066 96 (38.1) 92 (36.5) 0.713
Heart failure 44 (13.1) 48 (11.8) 0.583 33 (13.1) 32 (12.7) 0.894
Stroke 49 (14.6) 54 (13.2) 0.596 37 (14.7) 39 (15.5) 0.803
Pulmonary disease 42 (812.5) 40 (9.8) 0.243 27 (10.7) 26 (10.3) 0.885
Foot gangrene 73 (21.7) 135 (33.1) <0.0001 67 (26.6) 63 (25.0) 0.684
No. of affected angiosomes 2.2  1.0 2.2  0.7 0.723 2.2  1.1 2.2  0.7 0.768
Level of revascularization <0.0001 1.000
Crural 320 (95.2) 346 (84.8) 237 (94.0) 237 (94.0)
Pedal 16 (4.8) 62 (15.2) 15 (6.0) 15 (6.0)
Type of revascularization 0.106 0.848
Endovascular revascularization 237 (70.5) 265 (65.0) 173 (68.7) 171 (67.9)
Surgical revascularization 99 (29.5) 143 (35.0) 79 (31.3) 81 (32.1)
Type of bypass graft 0.655 0.828
Single saphenous vein graft 52 (52.5) 84 (58.7) 43 (54.4) 50 (61.7)
Other vein grafts 41 (41.4) 48 (33.6) 32 (40.5) 26 (32.1)
Composite vein plus prosthesis graft 4 (4.0) 7 (4.9) 3 (3.8) 3 (3.7)
Prosthesis graft 2 (2.0) 4 (2.8) 1 (1.3) 2 (2.5)
Data are reported for the overall population and propensity score matched pairs.
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surgery was associated with a signiﬁcantly higher rate of
wound healing than non-angiosome-targeted angioplasty
(p < .001, HR 2.265, 95% CI 1.605e3.196) (Fig. 2). Inter-
estingly, non-angiosome-targeted bypass surgery also ach-
ieved better wound healing rates than angioplasty
independently of the angiosome oriented strategy
(p ¼ .001, HR 1.890, 95% CI 1.292e2.766) (Figs. 1 and 2).Limb salvage
Univariate analysis showed that C-reactive protein
>10 mg/dL (p < .0001), CKD class 5 (p ¼ .005), diabetes
(p ¼ .020), atrial ﬁbrillation (p ¼ .030), and an increasing
number of affected angiosomes (p < .0001) were associ-
ated with decreased limb salvage rates. Angiosome-
targeted revascularization was associated with a trendtowards improved limb salvage (p ¼ .065, Table 2). The Cox
proportional hazards analysis demonstrated that an
increasing number of affected angiosomes (p < .0001, HR
1.439, 95% CI 1.206e1.717), atrial ﬁbrillation (p ¼ .028, HR
1.499, 95% CI 1.046e2.149), C-reactive protein >10 mg/dL
(p ¼ .002, HR 1.952, 95% CI 1.271e2.997), CKD class 5
(p ¼ .002, HR 2.285, 95% CI 1.354e3.856), and non-
angiosome-targeted revascularization (p ¼ .014, HR
1.531, 95% CI 1.088e2.154) were independent predictors
of major amputation. When included in this regression
model, non-angiosome-targeted angioplasty was associ-
ated with the highest risk of major amputation compared
with non-angiosome-targeted bypass surgery (p ¼ .049, HR
0.569, 95% CI 0.325e0.997), angiosome-targeted bypass
surgery (p ¼ .033, HR 0.589, 95% CI 0.362e0.958), and
angiosome-targeted angioplasty (p ¼ .005, HR 0.556, 95%
CI 0.371e0.834).
Figure 1. KaplaneMeier estimates of wound healing according to treatment method and angiosome-targeted revascularization (log-rank:
p < .0001).
Table 2. Outcome of patients who underwent angiosome-targeted or non-angiosome-targeted infrainguinal revascularization for critical
limb ischaemia.
Outcome endpoint Overall series Propensity matched pairs
Non-angiosome-targeted
336 pts
Angiosome-targeted
408 pts
p Non-angiosome-targeted
252 pts
Angiosome-targeted
252 pts
p
Wound healing 0.071 0.058
30-day 1.1% 2.3% 1.5% 2.8%
6-month 37.8% 47.0% 36.9% 41.1%
1-year 69.2% 72.1% 67.3% 71.6%
Survival 0.364 0.741
30-day 96.1% 96.6% 96.0% 95.6%
1-year 77.1% 78.5% 77.0% 76.0%
2-year 66.8% 69.8% 65.0% 65.2%
3-year 54.0% 57.2% 54.2% 51.1%
4-year 47.6% 50.6% 46.7% 39.0%
Limb salvage 0.065 0.019
30-day 89.1% 92.3% 87.1% 92.0%
1-year 77.5% 82.7% 74.7% 84.1%
2-year 74.7% 80.5% 71.5% 82.1%
3-year 72.0% 78.3% 69.8% 77.7%
4-year 69.8% 78.3% 69.8% 77.7%
Amputation free
survival
0.064 0.154
30-day 85.7% 89.2% 82.9% 87.7%
1-year 62.2% 66.5% 59.9% 65.3%
2-year 51.5% 58.4% 47.9% 55.7%
3-year 41.4% 47.3% 39.6% 42.8%
4-year 35.3% 43.8% 33.1% 36.0%
Data are reported for the overall population and propensity score matched pairs.
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Figure 2. Adjusted Cox proportional hazards estimates of wound
healing according to treatment method and angiosome-targeted
revascularization (p < .0001).
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A propensity score for angiosome-targeted or non-
angiosome-targeted revascularization strategy was calcu-
lated by means of logistic regression (Hosmer-Lemeshow’s
test: p ¼ .924, area under the ROC curve 0.630, 95% CI
0.590e0.670).
Propensity score matching with a caliper width of 0.02
resulted in 252 pairs with similar baseline and operative
characteristics (Table 1). Angiosome-targeted revasculari-
zation was associated with signiﬁcantly better limb salvage
and a trend towards improved wound healing (Table 2).Figure 3. Propensity score adjusted hazard of major amputation
according to angiosome-targeted and non-targeted revasculariza-
tion (p ¼ .010, HR 0.637, 95% CI 0.452e0.897).The propensity score adjusted analysis showed that
angiosome-targeted revascularization tended to lead to
improved wound healing (p ¼ .058, HR 1.275, 95% CI
0.992e1.639). When adjusted for propensity score and
treatment method (bypass surgery vs. angioplasty),
angiosome-targeted revascularization was associated with a
signiﬁcantly higher wound healing rate (p ¼ .046, HR 1.295,
95% CI 1.005e1.668). It is worth noting that, in this
regression model, bypass surgery was also an independent
predictor of a higher rate of wound healing (p < .0001, HR
1.720, 95% CI 1.354e2.185).
Angiosome-targeted revascularization yielded a signiﬁ-
cantly lower risk of major amputation (p ¼ .010, HR 0.637,
95% CI 0.452e0.897, Fig. 3) and better amputation free
survival (p ¼ .037, HR 0.788, 95% CI 0.630e0.986) in the
propensity score adjusted analysis. When treatment strat-
egy, that is bypass surgery versus angioplasty, was included
in this regression model, bypass surgery yielded a lower risk
of major amputation (p ¼ .070, HR 0.703, 95% CI 0.480e
1.029). Angiosome-targeted revascularization did not affect
patient survival (p ¼ .601, HR 1.071, 95% CI 0.828e1.384).Bypass surgery versus angioplasty in angiosome-targeted
revascularization
A propensity score was calculated to estimate the proba-
bility of being included in the bypass surgery or angioplasty
group among patients who underwent angiosome-targeted
revascularization. The obtained propensity score had an
area under the ROC curve of 0.774 (95% CI 0.724e0.824)
(Hosmer-Lemeshow’s test: p ¼ .378). Propensity score
adjusted analysis showed that bypass surgery was associ-
ated with a signiﬁcantly better rate of wound healing
(p ¼ .014, HR 1.536, 95% CI 1.091e2.162). However, an-
gioplasty and bypass surgery achieved similar limb salvage
rates (p ¼ .440, HR 0.791, 95% CI 0.437e1.434).
DISCUSSION
The idea of applying the angiosome concept to the treat-
ment of lower limb ischaemia with tissue lesions seems
attractive, and during the last decade, a number of studies
have been conducted to evaluate the efﬁcacy of angiosome-
targeted revascularization.3e6,9,10,13,14,16,20,21,24e26 Two
recent meta-analyses of the angiosome concept used in
treatment of CLI agreed on the considerable potential for
angiosome-orientated revascularization,18,19 as conﬁrmed
by the present results. Herein, it is observed that better
wound healing is associated with angiosome guided revas-
cularization, low C-reactive protein, and a low number of
affected angiosomes. Unlike previous studies,3e17 endo-
vascular revascularization was compared with surgical
revascularization using multivariate analysis as well as by
propensity score analysis in a large patient population.
Interestingly, better wound healing was observed in open
surgical revascularization, independently of the angiosome
orientation, rather than in angiosome-targeted or non-
targeted angioplasty. Limb salvage was signiﬁcantly better
if angiosome-targeted bypass was achieved, and non-
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highest risk of major amputation. When a comparison was
made between 252 propensity score matched pairs,
angiosome-targeted revascularization was associated with a
lower amputation rate than non-angiosome-targeted
revascularization.
It is clear that the patients who undergo angiosome-
targeted revascularization as opposed to non-targeted
revascularization are different regarding age, comorbid-
ities, and maybe also the severity of peripheral arterial
disease.27 Many patients are too fragile for open surgery
and the only option is endovascular revascularization.
Furthermore, in a large proportion of patients, the anatomy
of revascularization cannot be chosen as there may be only
one crural vessel left and the wound affects several
angiosomal regions.28 Therefore, the number of patients in
whom there is a real possibility to choose between
angiosome-targeted and non-angiosome-targeted revascu-
larization or between PTA and open bypass is limited. This
study demonstrates the beneﬁt of mastering both revas-
cularization methods. The endovascular ﬁrst strategy is
good when there is a possibility of achieving angiosome-
targeted revascularization. If not, however, the best op-
tion seems to be bypass surgery, regardless of the angio-
somal orientation.
When choosing between surgical and endovascular
revascularization, the completely different levels of inva-
siveness of the procedures must also be kept in mind. In
light of the arrested inﬂow to the periphery and blood loss
as a result of open surgery,29 endovascular procedures are
not just less invasive to the patient, but they also entail a
lower risk of post-operative infection arising from the sur-
gical wound as well as shorter hospitalization time.30
Currently, the policy for clinical practice at the institution
in this study is an endovascular ﬁrst strategy whenever the
pre-operative MR angiogram shows a sufﬁcient probability
of success. However, in cases in whom a high risk of failure
is expected after endovascular revascularization, mostly
patients with long arterial occlusions, open surgery is cho-
sen ﬁrst. The same decision is made if endovascular treat-
ment fails repeatedly. The majority of patients with CLI and
a tissue lesion are elderly women with diabetes mellitus
and its complications.27 In such cases, as non invasive an
intervention as possible is recommended. But would
“younger” patients with non-healing ulcers not beneﬁt
more from open surgery than angioplasty? The other
important factors to be considered when planning the
treatment are the number of affected angiosomes and C-
reactive protein level. According to the ﬁndings of this
study, in patients with several affected angiosomes and
elevated C-reactive protein, if angiosome-targeted angio-
plasty is not possible, it seems to be signiﬁcantly better to
perform angiosome-targeted bypass as a ﬁrst line treatment
and skip non-targeted angioplasty.
This study provides evidence that angiosome-targeted
revascularization results in higher wound healing and limb
salvage rates than non-targeted revascularization.3e7,9 To
evaluate the differences between surgical and endovascularrevascularization, a subanalysis was performed among pa-
tients who underwent angiosome-targeted revasculariza-
tion. In this comparison, bypass surgery was associated with
a better wound healing rate than endovascular revascular-
ization, but the limb salvage rates were similar. This com-
parison included a limited number of patients and the
results can be seen only as preliminary.
The possible reasons behind the differences between the
surgical and endovascular groups can only be speculated
upon. Most probably the patients in the surgery group had
more extensive arterial occlusive disease, and thus they
should not have better runoff and more limited tissue loss
than patients in the endovascular group. After bypass, an
arterial line with good diameter to perfuse the distal part of
the lower limb is achieved. After angioplasty, the size of the
arterial line is smaller and it is hypothesized that the
pressure impact may be smaller even after a targeted PTA
where an open line to the wound angiosome is achieved
compared with the bypass. The poor outcome after non-
targeted bypass is easier to understand: in these cases
the distal arterial tree is probably very diseased and allows
only limited revascularization, whereas in cases of non-
angiosome targeted bypass, again, the pressure change is
more dramatic compared with angioplasty.
A number of limitations may affect the results of this
study. It is retrospective and, even though the data have
been drawn from a prospectively collected database,
determination of the affected angiosome can be difﬁcult in
some cases. Photographs were included in the case his-
tories of many of the patients, and were found helpful in
this regard. Moreover, in some cases, the evaluation of
angiograms may be problematic because of poor image
quality as regards limitations in the examined region.
Furthermore, the deﬁnition of targeted revascularization in
cases where the ulcer spans several angiosomes is unclear.
In this study, the strategy was considered as targeted
revascularization if direct ﬂow was achieved to at least one
of the angiosomal arteries. Furthermore, it was not possible
to include ABI and toe pressures in the propensity score
analysis. This was because ABI was available in only 440
patients and toe pressure in 516 patients. However, in
comparison, there was no signiﬁcant difference between
ABI in the targeted and non-targeted groups (ABI 0.50 and
0.60 respectively, p ¼ .1). Toe pressures were higher in the
targeted group compared with the non-targeted group
(36 mmHg and 32 mmHg, p ¼ .04). The surgical group had
signiﬁcantly lower ABI and toe pressures than the endo-
vascular group (ABI 0.37 vs. 0.67, p < .001; and 28 mmHg
and 36 mmHg, respectively, p < .01). However, the analysis
of these parameters does not weaken the results, on the
contrary they strengthen the ﬁndings of different outcomes
after surgical and endovascular revascularization. On the
other hand, a strength of this study is the comprehensive
follow up in the majority of the patients and reliable data
on amputations and deaths. Furthermore, the number of
patients included is high, allowing for a strong propensity
score analysis and a high number of pairs matched by the
propensity score.
418 K. Spillerova et al.In conclusion, rates of wound healing and limb salvage in
patients with CLI were signiﬁcantly better after angiosome-
targeted revascularization. Bypass surgery seems to achieve
signiﬁcantly better wound healing than angioplasty.
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